Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.
about
Advances of stereotactic body radiotherapy in pancreatic cancerA current perspective on stereotactic body radiation therapy for pancreatic cancerNeoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report.The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and reviewHistopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer.Stereotactic body radiation therapy in pancreatic cancer: the new frontier.Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions.Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study.Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.Essential role of radiation therapy for the treatment of pancreatic cancer : Novel study concepts and established treatment recommendations.Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery.Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies.Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy
P2860
Q26781550-1498D808-1257-4591-93EC-DC7FB4489E97Q28077111-118DF07A-C28F-4109-B7E3-7957C82BD08DQ33750803-91DECD65-979E-4A4F-8328-4786EC13B68DQ35695811-11342501-47B7-40EA-BC4D-92C902ECBD13Q36130588-1692EF2A-9FB2-4ED9-8F26-096892493C7BQ36159880-882F5125-D9EF-4C75-ACCA-A72E7EEE11B4Q36666622-4A072DA0-7853-4420-A511-B49FBB3D9AEFQ36746016-EC1C280B-D285-43AE-9EE7-46FD35147781Q37131693-83813B25-2307-4AA0-8750-0AB3613933C6Q38245676-EFCD1F07-D04A-40FB-8FCC-3D34E053E1C5Q38415959-B34803E0-F16E-4135-8584-31C21E5BF499Q38783194-2BFAA0A9-5305-41AF-9751-639D8F4820BEQ38806110-FE1CFB72-483B-458C-BED9-B30D4A775D97Q39342560-6ED5E29E-DBF7-443E-BB25-71D1B02BAA48Q42374126-DE262153-B238-4142-9D64-363DCB27096CQ50221174-1F7FA67F-76E4-4C3A-AC05-E643691563F9Q53395999-EAC87CD2-3223-4EC0-93B1-949C10BB96E2Q55162030-2578F79A-55FA-4807-B9CE-EAC779371006Q55380602-C9682230-41C7-4365-B6E8-392F4ACD2800Q58784454-559DE4D8-EFF3-4061-9F3A-2766DD562885
P2860
Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@ast
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@en
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@nl
type
label
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@ast
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@en
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@nl
prefLabel
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@ast
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@en
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Pathologic response with neoad ...... ly-advanced pancreatic cancer.
@en
P2093
A James Moser
Alyssa M Krasinskas
Annette E Quinn
Barry Lembersky
Dwight E Heron
Herbert J Zeh
Malolan S Rajagopalan
Nathan Bahary
Randall Brand
Rodney E Wegner
P2860
P2888
P356
10.1186/1748-717X-8-254
P577
2013-10-31T00:00:00Z
P6179
1032710551